Occupational Asthma

Slide 1 · Occupational Asthma

Mechanisms, airway pathology, occupational assessment and prevention

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish

Occupational asthma from pre-existing asthma exacerbated at work.

Explain

How occupational sensitizers and irritants generate airway obstruction.

Recognize

Inflammation, remodeling, and clinicopathologic manifestations.

Investigate

The work association objectively and identify exposure controls.

Slide 3 · Asthma: The pathological foundation

Chronic airway inflammation is accompanied by variable expiratory airflow obstruction.

Wheezing, cough, chest tightness, and dyspnea vary over time and intensity.

Airway narrowing reflects bronchoconstriction, mucosal edema, and mucus.

Long-standing inflammation can produce persistent structural remodeling.

Slide 4 · Two entities within work-related asthma

Occupational asthma

Work-exacerbated asthma

New asthma attributable to workplace exposure

Pre-existing asthma becomes worse because of workplace conditions

May arise through sensitization or irritant mechanisms

The workplace aggravates asthma rather than necessarily initiating it

Both demand careful exposure history and objective assessment

Both demand symptom control and reducing relevant exposures

Slide 5 · From workplace exposure to symptomatic disease

Exposure

Fumes, dusts, chemicals, or gases

Mechanism

Sensitization, mediator release, or irritant injury

Airway response

Smooth muscle contraction + edema + mucus

Manifestation

Variable expiratory airflow obstruction

Schematic — causal pathways vary by agent.

Slide 6 · Robbins: Four occupational exposure groups

Fumes

Epoxy resins; Plastics

Dusts

Wood; Cotton; Platinum

Gases / vapors

Toluene

Other chemicals

Formaldehyde; Penicillin products

Representative textbook examples, not an exhaustive list.

Slide 7 · Epoxy resin exposure: A source of fumes

Fumes from epoxy resins as possible triggers.

The implicated agent and exposure route must be established for an individual worker.

Do not assume that every episode following fume exposure is IgE-mediated.

Connect specific work tasks with the timing of new or worsening symptoms.

Slide 8 · Plastics: Exposure is task-dependent

Fumes associated with plastics appear’ occupational trigger list.

The term “plastics” spans different materials and processing conditions.

A material inventory and task description are more informative than job title alone.

Mechanistic attribution should not exceed what exposure testing establishes.

Specific agent identification requires occupational assessment.

Slide 9 · Dust-associated exposures

Wood

Inhaled wood dust can be associated with asthma symptoms.

Cotton

The workplace history should distinguish asthma from other dust-associated diseases.

Platinum

Platinum among chemical or organic dust triggers.

Slide 10 · A named exposure does not prove causation

Finding dust or fumes in the workplace establishes possible exposure—not occupational asthma.

Asthma must be demonstrated clinically and physiologically.

A reproducible work association strengthens attribution.

Competing causes or mimics still require evaluation.

Slide 11 · Toluene and volatile exposures

Toluene in its examples of occupational triggers.

Workplace solvent use may produce inhaled vapor exposure.

Symptoms should be tied to specific activities and ventilation conditions.

An occupational agent list alone cannot establish an immune mechanism.

Slide 12 · Other chemical triggers

Formaldehyde

A listed chemical associated with occupational asthma.

Penicillin products

A listed occupational pharmaceutical-product trigger.

Clinical question

Is the exposure associated with new asthma or merely worsening of established asthma?

Slide 13 · Repeated exposure and sensitization

Initial contact

Workplace substance is inhaled

Latent interval

Some workers develop immune sensitization

Re-exposure

Airway response may follow a subsequent exposure

Symptoms

Even low exposure may precipitate an attack

Robbins: Repeated exposure is usual; This is not a universal mechanism.

Slide 14 · Very small quantities can provoke attacks

Minute quantities of certain chemicals may precipitate an attack.

This observation fits sensitization-associated reactivity after repeated exposure.

The threshold cannot be inferred for an individual worker from the textbook.

Low ambient levels do not necessarily imply safety for a sensitized worker.

Slide 15 · Sensitizers and irritants: Different pathways

Sensitizer-associated

Irritant-associated

Typically follows a latency period before sensitization

Can reflect nonallergic airway injury

A specific immune response is implicated

May follow a high-level exposure without latency

Re-exposure may cause symptoms at low quantities

Gases, fumes, vapors, and aerosols are relevant irritants

Immunologic tests may help for some agents

Negative IgE testing does not exclude the mechanism

Slide 16 · Sensitizer-associated asthma has a latency period

An immunologic response develops after exposure begins.

NIOSH describes a latency period commonly lasting at least several months.

The worker may initially tolerate the environment without respiratory symptoms.

After sensitization, subsequent exposures can trigger disease.

Slide 17 · High-molecular-weight occupational sensitizers

NIOSH examples include flour, grain and wood dust, latex, and plant proteins.

Specific IgE antibodies can participate in the response.

Re-exposure cross-links mast-cell-bound IgE and releases mediators.

The diagnosis still requires linking the demonstrated asthma to work.

Slide 18 · Low-molecular-weight occupational sensitizers

NIOSH examples include diisocyanates, anhydrides, acrylates, and metals.

Some substances act as haptens after binding to host proteins.

An IgE test is not a universal diagnostic test for all low-molecular-weight agents.

Mechanisms are heterogeneous and may not fit one allergic model.

Slide 19 · Hapten-dependent sensitization: Conceptual model

Small molecule

Incomplete antigen (hapten)

Protein binding

Creates a potentially sensitizing complex

Immune response

Sensitization develops in some exposed workers

Re-exposure

Potential asthma response

Schematic: Applies to some low-molecular-weight agents; Not all occupational asthma.

Slide 20 · Irritant-associated asthma is not necessarily allergic

Irritant gases, fumes, and aerosols can produce nonallergic airway responses.

The underlying biology is less well characterized than classic IgE-mediated asthma.

An intense exposure may cause new-onset asthma without an immunologic latency.

Distinguish irritant-induced disease from a pre-existing asthma exacerbation.

Slide 21 · Latency clarifies exposure mechanisms

Feature

Sensitizer-associated

Irritant-induced

Typical exposure pattern

Repeated exposure

Can follow an intense episode

Latency

Usually present

May be absent

Mechanism

Immune sensitization possible

Nonallergic airway injury possible

Core proof

Asthma + work relation

Asthma + credible irritant exposure

Slide 22 · Robbins: Occupational mechanisms are heterogeneous

Type I reaction

IgE-associated immediate hypersensitivity in susceptible settings.

Mediator release

Direct liberation of bronchoconstrictor substances.

Other hypersensitivity

Responses of incompletely understood origin.

Avoid equating occupational asthma with atopic asthma in every patient.

Slide 23 · Phenotype and trigger are separate dimensions

Atopic asthma

Nonatopic asthma

Occupational asthma

Evidence of allergen sensitization

No evidence of sensitization

Defined by causal workplace association

Frequently type 2 / IgE-driven

May involve infections or pollutants

Can involve immune or nonimmune processes

Categories are not wholly exclusive

Symptoms overlap

Exposure history becomes essential

Slide 24 · IgE-mediated early response: Conditional pathway

Antigen

A relevant sensitizer is inhaled

Cross-linking

Mast-cell surface IgE is cross-linked

Mediator release

Granule mediators and new products

Airway effect

Bronchospasm + permeability + mucus

Model applies when occupational asthma has a type I mechanism.

Slide 25 · Th2 immunity: IL-4 promotes IgE production

Th2 lymphocytes help coordinate type 2 airway inflammation.

IL-4 promotes immunoglobulin E production by B cells.

IgE can bind Fc receptors on mucosal mast cells.

In a sensitized airway, antigen re-exposure may initiate a rapid reaction.

Slide 26 · Th2 immunity: IL-5 recruits eosinophil effects

IL-5 supports activation of recruited eosinophils.

Eosinophils contribute to the late inflammatory reaction.

Eosinophil products may damage airway epithelium.

An eosinophilic phenotype is not mandatory in every occupational case.

Slide 27 · Th2 immunity: IL-13 promotes mucus secretion

IL-13 stimulates secretion from bronchial submucosal glands.

It also contributes to the IgE-favoring type 2 response.

Mucus increases the luminal obstruction caused by smooth muscle contraction.

Excess mucus is one reason airflow obstruction can outlast the immediate trigger.

Slide 28 · Immediate and late inflammatory phases

Early response

Mast cell mediators → bronchospasm, edema, mucus

Cell recruitment

Eosinophils, neutrophils, T lymphocytes enter airway

Late response

Additional mediators and epithelial damage

Cumulative injury

Recurrent episodes can support remodeling

Slide 29 · Inflammatory participants in asthma

Mast cells

Rapid mediator release after appropriate activation.

Eosinophils

Inflammation and epithelial injury in type 2 disease.

T lymphocytes

Cytokine-driven inflammatory coordination.

Neutrophils

Can dominate in a subset of severe disease.

Slide 30 · Cysteinyl leukotrienes sustain bronchoconstriction

Leukotrienes C₄, D₄, and E₄ can cause prolonged bronchoconstriction.

They also increase mucus secretion and vascular permeability.

Their role is supported by clinical effects of leukotriene antagonism.

Multiple mediators contribute; There is no single universal asthma pathway.

Slide 31 · Parasympathetic signaling narrows airways

Acetylcholine released from parasympathetic nerves stimulates muscarinic receptors.

Airway smooth muscle contraction reduces the airway lumen.

Local and central vagal reflexes may contribute to the early response.

This neural pathway can amplify inflammation-driven bronchospasm.

Slide 32 · Three immediate contributors to airflow obstruction

Bronchoconstriction

Contracted airway smooth muscle reduces lumen caliber.

Wall edema

Inflamed, permeable vessels increase mucosal thickness.

Mucus

Viscous secretions occupy the already narrowed lumen.

Slide 33 · Healthy and asthmatic airway: Structural contrast

Uninvolved airway

Remodeled asthmatic airway

Thin wall · broad patent lumen

Thickened wall · narrowed lumen · mucus

Schematic; Not a patient specimen

Slide 34 · Gross appearance in severe asthma

The lungs may be overinflated during a fatal acute severe attack.

Small regions of atelectasis may coexist with hyperinflation.

Bronchi and bronchioles can be occluded by tenacious mucus plugs.

These are established findings in asthma generally—not occupational-specific signatures.

Slide 35 · Goblet-cell and mucous-gland enlargement

Goblet-cell numbers increase within the airway epithelium.

Submucosal mucus-secreting glands become enlarged.

Excess mucus can accumulate inside narrowed conducting airways.

Mucus burden increases airway resistance and impairs ventilation.

Slide 36 · Sub–basement membrane fibrosis

Collagens type I and III accumulate beneath the epithelial basement membrane.

The airway wall becomes structurally thickened.

This is a component of remodeling after chronic inflammation.

Structural change can contribute to less fully reversible obstruction.

Slide 37 · Smooth muscle hypertrophy and hyperplasia

Airway smooth muscle mass increases in chronically remodeled bronchi.

More muscular tissue thickens the bronchial wall.

Muscular constriction still drives much of the acute airflow reduction.

Together these changes contribute to increased airway responsiveness.

Slide 38 · Increased airway vascularity

Remodeled asthmatic airways can exhibit increased vascularity.

Inflammatory vascular permeability also contributes to acute wall edema.

Vascular alterations narrow the effective lumen indirectly.

Separate chronic vascular remodeling from transient inflammatory swelling.

Slide 39 · Why repeated attacks can leave persistent obstruction

Repeated inflammation

Epithelial damage and cytokine signaling

Repair / growth factors

Mucous glands, vessels and muscle expand

Collagen deposition

Subepithelial fibrosis develops

Remodeled airway

A chronic fixed component may coexist with reversibility

Slide 40 · Curschmann spirals and mucus plugs

Curschmann spirals are twisted mucus structures in sputum or airway samples.

They may result from extrusion of mucus plugs from small airway structures.

They support an asthmatic inflammatory process in context.

They cannot identify which workplace substance caused the disease.

Slide 41 · Charcot–Leyden crystals: Eosinophil origin

Crystals associated with eosinophils contain galectin-10.

Them in sputum from atopic asthma.

They may accompany mucus plugging and eosinophilic inflammation.

Neither crystals nor eosinophils alone prove occupational causation.

Slide 42 · Clinical manifestations resemble ordinary asthma

Wheezing, cough, chest tightness, and shortness of breath are typical.

Symptoms may fluctuate substantially between exposures.

A worker may have normal examination findings between attacks.

Clinical similarity makes occupational and nonoccupational asthma hard to separate without history.

Slide 43 · Work-related symptoms may be delayed

Symptoms can begin during an exposure or several hours after a work shift.

Evening symptoms do not exclude a workplace trigger.

Severe disease may persist on nonworking days.

The full weekly pattern is more useful than asking about wheeze only at work.

Slide 44 · Work association: Temporal clues

New job

Symptoms begin after employment or a change in work tasks.

New material

A new chemical or process precedes symptoms.

Time away

Symptoms may improve on weekends or holidays.

Return to work

Symptoms may recur or worsen after exposure resumes.

Slide 45 · Occupational history: First-line clinical instrument

Record current and previous jobs and detailed work tasks.

Identify substances, dusts, gases, fumes, and process changes.

Ask whether symptoms are better during weekends, holidays, or time off.

Document onset timing relative to exposure and changes in medication use.

Slide 46 · Exposure history: Ask about the task, not only the job

Question

Interpretive role

What material is handled?

Identifies candidate substances

How is it processed?

Highlights fumes, dust, or aerosol formation

When did the task begin?

Tests temporal plausibility

What happens away from work?

Screens for work association

Are coworkers affected?

May prompt workplace exposure assessment

Slide 47 · Diagnosis requires two linked demonstrations

Step 1

Establish the patient has asthma

Step 2

Establish a credible association with work

Step 3

Identify likely exposure and mechanism

Step 4

Assess alternatives and management implications

Symptoms alone are insufficient to identify an occupational cause.

Slide 48 · Spirometry: Confirm variable airway obstruction

Spirometry evaluates the degree of expiratory airflow limitation.

Bronchodilator reversibility supports a diagnosis of asthma when obstruction is present.

A normal test between attacks does not necessarily exclude asthma.

Work causation requires additional exposure-linked evidence.

Slide 49 · Bronchial challenge when baseline spirometry is normal

If asthma remains suspected despite normal spirometry, bronchial responsiveness can be assessed.

Methacholine or mannitol challenge are examples cited by NIOSH.

Airway hyperresponsiveness supports asthma but does not alone identify the workplace cause.

Testing decisions and interpretation belong to experienced clinicians.

Slide 50 · Serial peak expiratory flow: Work versus rest

Record repeated peak expiratory flow measurements during working and nonworking periods.

Look for reproducible airflow differences associated with exposure.

Measurements should span several weeks for interpretation.

A short isolated cross-shift measurement can miss delayed or intermittent reactions.

Slide 51 · A practical peak-flow diary schedule

Working days

Before, during and after the work shift

Nonworking days

Repeated measures across the day

Every day

Include a bedtime measurement

Record context

Exposure, symptoms, and medication use

NIOSH recommends four daily readings off work and serial workday readings.

Slide 52 · Interpret a period away from work carefully

Improvement in peak flow or bronchial responsiveness away from work supports association.

Recovery may be incomplete or delayed in severe disease.

Absence of a clear holiday effect cannot definitively exclude work-related asthma.

Do not prescribe deliberate harmful re-exposure merely to demonstrate a pattern.

Slide 53 · Specific IgE or skin testing: Limited scope

Demonstrating sensitization can support an allergic mechanism for some agents.

A positive test alone does not prove clinical occupational asthma.

Many low-molecular-weight exposures lack straightforward immune testing.

Negative allergy tests do not exclude irritant-induced or non-IgE disease.

Slide 54 · FeNO measures inflammation, not workplace causality

Fractional exhaled nitric oxide is a marker of allergic airway inflammation.

An increased result does not distinguish occupational from nonoccupational asthma.

A normal result does not rule out work-related asthma.

Interpret biomarkers only as adjuncts to clinical and physiologic findings.

Slide 55 · Specific inhalation challenge needs specialist oversight

Controlled challenge may identify a causative agent when uncertainty remains.

The procedure can provoke severe or delayed bronchoconstriction.

NIOSH surveillance guidance confines it to experienced facilities with emergency resources.

It is usually unnecessary for routine clinical diagnosis.

Slide 56 · Key differential diagnoses in the working adult

Differential

Discriminating issue

COPD

Persistent airflow limitation; Competing exposures

Nonasthmatic eosinophilic bronchitis

Chronic cough without typical variable obstruction

Hypersensitivity pneumonitis

Predominant parenchymal rather than airway disease

Inducible laryngeal obstruction

Upper-airway symptoms may mimic wheeze

Obliterative bronchiolitis

Persistent small-airway obstruction

Slide 57 · Integrated diagnostic reasoning

New or worsening asthma

Screen work history

Possible work trigger

Confirm asthma objectively

Pattern and exposures

Serial airflow assessment at and away from work

Joint interpretation

Specialist and occupational assessment as needed

The pathway is an educational synthesis, not a substitute for guidelines.

Slide 58 · Exposure elimination is a central intervention

NIOSH identifies eliminating relevant exposures as the best approach.

Exposure reduction through workplace controls may offer benefit.

Individual restrictions or reassignment may be necessary.

Continued exposure can undermine otherwise appropriate clinical care.

Slide 59 · Clinical treatment and workplace prevention coexist

Medical therapy addresses bronchospasm and airway inflammation.

Workplace controls address the underlying exposure.

Bronchodilators, glucocorticoids, and leukotriene antagonists among asthma treatments.

Selection of therapy follows current asthma guidance and individual severity.

Slide 60 · Workplace assessment: Actionable materials

Request Safety Data Sheets for products and processes used.

Consider industrial hygiene and occupational health consultation.

Evaluate ventilation, work practices, and exposure controls.

Maintain careful clinical documentation because job changes may have socioeconomic consequences.

Slide 61 · Case 1: Epoxy-resin workshop

A worker develops episodic wheeze and chest tightness after months in a job involving heated resin mixtures. Symptoms recur after certain tasks and sometimes begin in the evening.

What mechanism and investigations should be considered?

Slide 62 · Case 1: Reasoning from exposure to evidence

The repeated-exposure interval makes sensitization plausible but not certain.

Establish variable airway obstruction by spirometry or other objective testing.

Document symptoms, tasks, and serial peak-flow patterns at and away from work.

Identify the exact substance and involve occupational assessment.

Slide 63 · Case 2: Flour-processing worker

A previously healthy worker develops cough and wheeze after prolonged employment in a grain-processing area. Symptoms often improve on weekends.

Which evidence would strengthen the diagnosis of sensitizer-associated occupational asthma?

Slide 64 · Case 2: Distinguishing association from proof

Flour and grain proteins are recognized high-molecular-weight sensitizers.

The latency and work-rest pattern support a possible occupational connection.

Demonstrate asthma and work-related change in lung function.

Specific sensitization testing may be useful, but cannot replace objective assessment.

Slide 65 · Case 3: A major fume release

An adult without a previous asthma history develops wheezing and chest tightness soon after an unusually intense accidental inhalation of irritant fumes at work.

Why should the clinician not require an allergic latency period?

Slide 66 · Case 3: Interpret the acute exposure pattern

High-level irritant exposure may produce new asthma without sensitization latency.

Document the exposure, initial symptom timing, and persistent physiological abnormalities.

Exclude mimics and distinguish from transient airway irritation.

Avoid treating a presumed immune mechanism as established without evidence.

Slide 67 · Four enduring diagnostic principles

Recognize

Consider workplace factors in any adult with new or worsening asthma.

Differentiate

New workplace-induced asthma is not the same as work-exacerbated asthma.

Demonstrate

Use objective respiratory testing and work-related serial measurements.

Prevent

Identify and eliminate the relevant exposure whenever feasible.

Slide 68 · Selected source material

Primary pathology

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. 2026; Ch. 15, pp. 622–626.

Work-related taxonomy

CDC/NIOSH. Information for Clinicians. Updated February 25, 2025.

Diagnostic approach

CDC/NIOSH. Diagnosing Work-related Asthma. Updated February 25, 2025.

Surveillance definition

CDC/NIOSH. Work-related Asthma Reporting Guidelines. Updated February 25, 2025.

Exposure management

CDC/NIOSH. Treating Work-related Asthma. Updated February 25, 2025.